This paper attempts to provide an answer to some questions that remain either poorly understood, or not well documented in the literature, on basic issues related to intensity modulated radiation therapy (IMRT). The questions examined are: the relationship between degeneracy and frequency response of optimizations, effects of initial beamlet fluence assignment and stopping point, what does filtering of an optimized beamlet map actually do and how could image analysis help to obtain better optimizations. Two target functions are studied, a quadratic cost function and the log likelihood function of the dynamically penalized likelihood (DPL) algorithm. The algorithms used are the conjugate gradient, the stochastic adaptive simulated annealing and the DPL. One simple phantom is used to show the development of the analysis tools used and two clinical cases of medium and large dose matrix size (a meningioma and a prostate) are studied in detail. The conclusions reached are that the high number of iterations that is needed to avoid degeneracy is not warranted in clinical practice, as the quality of the optimizations, as judged by the DVHs and dose distributions obtained, does not improve significantly after a certain point. It is also shown that the optimum initial beamlet fluence assignment for analytical iterative algorithms is a uniform distribution, but such an assignment does not help a stochastic method of optimization. Stopping points for the studied algorithms are discussed and the deterioration of DVH characteristics with filtering is shown to be partially recoverable by the use of space-variant filtering techniques.
Introduction
This paper seeks to provide an answer to some questions that have arisen in intensity modulated radiation therapy (IMRT) in the last few years that, either have not been well understood or have not been documented in the literature. One of these questions is exemplified by a growing awareness in the research community that the optimized beamlet fluxes to be delivered to a patient can be 'degenerate'. This has been taken to mean that there can be a number of different plans obtained from an identical set of dose requirements, delivering similar dose distributions to the patients and with almost identical final target function values, but with strongly different beamlet fluences. Alber and Nüsslin (2000) observed that degeneracy can help obtain smoother beamlet profiles by using a minimal surface smoothing constraint during optimization. Alber et al (2002) published a very elegant mathematical treatment of the degeneracy of the IMRT optimization problem and Llacer et al (2003) described one clear case of degeneracy in a prostate optimization. In this paper we want to make a clear distinction between degeneracy, as described above, and multiple extrema in an optimization with dose-volume (D-V ) constraints. Multiple extrema have been treated extensively in the literature: Deasy (1997) reported a set of conditions under which an optimization problem with dose-volume constraints can exhibit multiple local minima, Wu and Mohan (2001) reported obtaining multiple minima in a simple mathematical phantom but not in one intensity modulated radiation therapy case with a relatively high degree of symmetry. Chui and Spirou (2001) showed the presence of multiple local minima in a schematic treatment planning case with dose-volume constraints which had a design consistent with the discussion by Deasy. Rowbottom and Webb (2002) and Wu and Mohan (2002) used initialization by random beamlet weights to explore the space of solutions that could lead to multiple extrema. More recently, Wu et al (2003) developed a method of intercepts in parameter space for the purpose of studying local minima and Llacer et al (2003) demonstrated the small effects of multiple minima in seven different clinical cases. Multiple extrema effects are to be distinguished from degeneracy by the fact that optimizations are usually carried out to a very high number of iterations under different initialization conditions in order to study the possible different convergence points, while degeneracy is observable as very different outcomes of optimizations at an earlier, clinically useful stopping point. Jeraj et al (2003) studied both the effects of optimizer convergence errors (degeneracy) and local minima error (multiple minima) in a nasopharingeal tumour case and reported small differences in clinical TCP or NTCP measures for the former but significant differences in the latter. One of their results will be discussed briefly at the appropriate point in the work presented here.
We have found that the degeneracy issue is closely related to the stopping point of an iterative procedure and to the starting set of beamlet weights, two issues that appear not to have been studied thoroughly. The effect of filtering of beamlet weights in IMRT optimization has, likewise, not been studied carefully, beyond accepting that filtering is needed for the delivery of optimized results by multi-leaf collimators (MLCs), although it results in some deterioration of the optimization. It is the purpose of this paper to go beyond the mathematical treatment of Alber and show the relationship between degeneracy, the stopping point of an iterative algorithm, the spatial frequency response of the inversion process and the initial set of beamlet weights. Finally, the filtering process is studied in some detail and a methodology is proposed in a very preliminary form to minimize its effects on the quality of the optimizations.
The paper begins with a description of the two target functions studied: a quadratic cost function and log likelihood function of the dynamically penalized likelihood (DPL), and it introduces the notation used. The three algorithms used for the optimizations, the conjugate gradient (CG), the adaptive simulated annealing (ASA) and the DPL are then described briefly. The paper then presents, in an abbreviated form, the salient points of the work by Alber and it shows the connection between that work and the frequency response of the inversion process. A simple two-dimensional phantom that allows a reasonable visual representation of the results is used to describe the analysis methods of the paper and that is followed by the analysis of two clinical problems of medium and large dose matrix size, respectively: a meningioma (891 beamlets) and a prostate case (2995 beamlets). The effect of the starting initialization of beamlet weights in iterative optimization is studied next and a recommendation on stopping point is made based on the observations in the two clinical cases mentioned above. Finally, nonlinear Bayesian, linear Gaussian and median filters are studied for their effects on the quality of the resulting dose-volume histograms (DVHs) and the minimization of those effects by the use of a space-variant filter is presented in a very simple two-dimensional case.
Target functions
Two different target functions have been investigated, a quadratic cost function and the log likelihood target function of the dynamically penalized likelihood. Both target functions have been discussed in detail in and will be repeated here briefly. No filtering of the beamlet weights is included in the analysis part of the current work. Likewise, priority or importance factors of the OAR voxels with respect to PTV voxels have been left out.
The target function for the quadratic cost problem is given by
where D is the region that includes all PTV voxels, S the region that includes all OAR voxels, d i the dose desired in a specific voxel of the PTV, s i the dose desired in a specific voxel of an OAR, a the vector of beamlet fluences with elements a j , h i = j F ij a j the dose received by voxel i and F ij the elements of the dose matrix F, dose delivered by beamlet j to voxel i per unit beam fluence.
The target function of equation (1) will be used in two different contexts: (1) without the condition (h i − s i ) > 0 in the summation over OAR terms, for the analysis of problems in which the doses s i are exact desired doses and (2) with that condition present for problems in which the s i are obtained from maximum OAR desired doses and/or from dose-volume constraints. In the first case the two summations of equation (1) can be expressed as a single summation over all voxels.
The target function to be maximized for the DPL is given by the log likelihood function
with the same notation given above. The two cases referring to the condition on the second summation will also apply to equation (2) . As discussed in , this target function, when converted from Poisson distributed variables to Gaussian variables, is approximately equal to a quadratic cost function, but its maximization automatically excludes negative beamlets.
Algorithms
Optimizations with the quadratic cost function of equation (1) have been carried out with the conjugate gradient algorithm, basically in the implementation of Numerical Recipes (1988) with enhancements described by Spirou and Chui (1998) and in . They can be stated briefly by: (1) the line search for a minimum of a quadratic cost function can be carried out exactly in a single step, which strongly speeds up the solution and (2) when one or more beamlets have become negative at the end of one iteration, the travel along the gradient line is curtailed so that exactly all negative beamlets become non-negative. When this happens, the CG process has to be restarted, as the information from the previous iteration cannot be used to calculate the conjugate gradients. If negative beamlets appear frequently, the CG method becomes, in effect, a gradient descent with line search, which is considerably slower than the CG. Optimizations with the log likelihood function of equation (2) have been carried out with the iterative function described in without the filtering terms, given by
F ij is a normalization factor and k is the iteration number. The two cases indicated above for the condition on the second summation will be investigated.
Stochastic optimizations have also been carried out with the quadratic cost function of equation (1) . The algorithm used is the adaptive simulated annealing (ASA) algorithm described in . This algorithm was also used in a study of multiple local minima in Llacer et al (2003) . The annealing temperature has been set to zero, i.e., no annealing has been contemplated, as the problems studied do not appear to exhibit any multiple minima. The initial test step size, the schedule for decreasing it with increasing iterations and the termination criterion have been set as in the referenced work and can be summarized as follows: initial step size is 0.5 × average beamlet size when the PTV dose is normalized to the desired dose after random positive initialization; step size decrease function is an exponential decay with a 'time constant' of 300 iterations to a minimum fraction of 0.0001 of the initial average beamlet size; termination takes place when 10 consecutive iterations have changes in the square root of the cost that is smaller than 0.000 01, relative to the square root of the cost after the first iteration. Variations on the algorithm specific parameters have been often tested within a reasonable range without any significant change in the results.
The eigenvalues of the Hessian
This section presents an abbreviated version of the mathematical treatment of Alber using the notation described above for the target functions of equations (1) and (2) . Given a twice differentiable target function T (a), a solution a * will be degenerate if there are vectors χ = 0 such that
for all sufficiently small ε > 0. For that condition to be possible, it is necessary that χ be an eigenvector of the Hessian matrix H * with vanishing eigenvalue. For target functions normally used in IMRT optimization, the terms of the Hessian can be obtained from
where the target function T is now considered a function of the delivered doses h i (by the chain rule of differentiation). The number of eigenvectors of the Hessian with very small eigenvalues can be a measure of the null eigenspace of H * , the space in which the gradients are very small during an iterative optimization. The solution a can practically end up anywhere around that very flat bottom of the cost function. The starting point of the solution could then have a significant influence on the end point.
For the unconstrained quadratic cost function of equation (1), equation (5) becomes simply
and for the unconstrained log likelihood function, it is
The convergence of the log likelihood function is then dependent on the value of the desired doses d i and by the attained doses h i . However, d i ≈ h i towards convergence and equation (7) reduces to
The minus sign in equations (7) and (8) is proper for a maximization problem. The eigenvectors of H * are differential changes, i.e. small eigenvalues represent small curvatures in parameter space.
Eigenvector solutions to the inverse problem
Equation (6) is immediately reminiscent of the solution of an inverse problem by eigenvector decomposition. Consider the unconstrained problem at hand, in which the doses desired in the OAR are specified exactly and the condition (h i − s i ) > 0 is removed from equation (1) . We need to solve for the beamlet fluences a the set of simultaneous equations
If we multiply both sides by F , the transpose of F, we obtain
and letting F F = G and F d = b, the problem to be solved becomes
Vector b is a 'backprojection' of the desired doses d in configuration space into the parameter space of a, the beamlet fluence space. Andrews and Hunt (1977) , for example, describe a method for solving the problem of equation (11) by the use of eigenvector decomposition. A discrete version of the process follows: let the eigenvectors and eigenvalues of G be given by χ j and λ j respectively. The eigenvectors form a basis for any solution a to the problem. We can then expand that solution as
with the values of ξ j to be determined. Since eigenvalues and eigenvectors are defined by the equation
where I is the identity matrix, we can write from equations (11), (12) and (13)
Similarly the backprojected desired doses b can be expanded as
the dot product of the vectors, because of the orthogonality of the eigenvectors. Then, from equations (14) and (15), we find that
and finally,
In the context of the present investigation, it is to be noted that the elements of matrix G are given by
which, except for a factor of 2, are identical to those of the Hessian for the quadratic cost function (6). The implications of that similarity are discussed in detail below. In the case of image reconstruction, the presence of small eigenvalues results in a magnification of noise that may exist in the data b, as the eigenvalues appear in the denominator of equation (17). In the IMRT optimization problem there is no noise in the data (the backprojected desired doses in the PTV and OARs).
It is important to realize that the treatment of Alber and an inversion by eigenvector decomposition only apply exactly to totally unconstrained problems, i.e., when negative beamlet weights are allowed and no maximum value and/or D-V constraints for OAR doses have been specified. The significance of the eigenvalues/vectors of the Hessian and the ability to obtain a solution by eigenvalue decomposition of the unconstrained problem has, however, substantial implications for the optimization of the constrained clinical cases: the dose matrix F is the same for the unconstrained as for the constrained case. Any solution of the constrained problem has to be formed by linear combinations of the eigenvectors of the Hessian and the existence of very flat regions in parameter space, as described by small eigenvalues, can make the optimization of a problem as difficult for one case as for the other. Section III (results) in Alber's paper gives support to the above statement and there is evidence in the following material to support it experimentally.
Analysis methods

Two-dimensional phantom
The methods developed to study degeneracy in IMRT optimization can best be illustrated with reference to a simple phantom, where the number of variables to be represented graphically is reasonably small. Figure 1 shows a water-equivalent U-shaped PTV and a circular OAR in a 20 cm diameter water circle. It represents a single 5 mm layer with 2 × 2 mm voxels. The irradiation is by five equi-angular beams at 0, 36, 72, 108 and 144
• , with the beam at 0
• entering the phantom from below and the angle increasing counterclockwise. The 54 beamlets of the problem have a cross section of 4 mm × 5 mm and their dose matrix F has been calculated using a public domain programme from the University of Wisconsin that includes all scattering terms. Because the phantom is not exactly symmetrical and is not exactly centred in the water cylinder, the number of beamlets is not the same in each beam.
We discuss first the totally unconstrained problem, not only without the OAR inequalities of equations (1) and (2), but also allowing negative beamlet weights. Figure 2 shows a plot of the 54 eigenvalues of the Hessian, obtained with MATLAB's 'eig' function in double precision (2001) . Note that the ordinate is logarithmic. There is, indeed, a substantial fraction of eigenvalues that are quite small relative to the first one. Two curves are shown, corresponding to the Hessian for the quadratic cost function and for that of the log likelihood function, normalized to the same maximum. The two condition numbers, defined as the largest eigenvalue divided by the smallest one, are 3.56 × 10 6 and 3.08 × 10 6 , respectively. There are some minor differences between the two sets of eigenvalues, but essentially, the condition discussed by Alber for the existence of degeneracy appears to exist, at least with respect to the last nine eigenvalues. It is interesting to 'project' the eigenvectors χ j from their parameter space onto configuration space by the simple multiplication Fχ j , yielding images of which voxel doses are represented by each eigenvector. Figure 3 shows the images for the 54 projections for the case of the quadratic cost function, normalized to a single maximum. They correspond to increasingly higher spatial frequency information in the configuration space of patient doses. Note that the zero level is represented by mid-grey. The connection between Alber's analysis and the eigenvector decomposition becomes now quite clear: if an iterative optimization cannot reach into the region in parameter space where the small eigenvalues result in a rather flat minimum, the attaining of high spatial frequencies in the optimized dose distributions may be difficult and perhaps not possible. High frequencies in the dose distributions may be a necessity because of the specification of a uniform desired dose with sharp edges in the PTV, particularly in regions adjacent to an OAR, or when relatively small 'boost' regions are specified inside a PTV. Figure 4 shows the beam fluences resulting from the solution of the optimization problem by eigenvector decomposition, using equation (18). It has been assumed that the desired dose is exactly 100 units for the PTV and exactly 40 units for the OAR. The dose units used for the phantom are related by Gy units by a constant factor. Figure 5 shows the doses delivered by the optimized set of beamlets to the two regions. Doses outside those regions are not shown as they contain negative and positive doses in complicated patterns that are irrelevant at this point in the study.
Unconstrained case
Eigenvector and conjugate gradient solutions.
CG solutions have been carried out stopping the iterative process at 200 iterations, with 10 different randomly initialized beamlet weights that will be termed 'realizations'. The CG algorithm was modified to accept negative beamlets as part of the solution. The results of the 10 realizations have been analysed by calculating the correlation coefficients between the coefficients with the eigenvector solution of 0.9999 or higher and they have lost 'memory' of their random initialization. One can then conclude that there is no trace of degeneracy in this problem, except if terminated after a low number of iterations. It should be pointed out that the CG is very efficient in solving this unconstrained case because the beamlet weights are allowed to become negative and the conjugate gradient vectors can be calculated correctly at each iteration.
Results with constraints
The restriction of non-negativity of beamlet fluences along with the specification of maximum dose and D-V constraints on the OAR have been applied and the CG, ASA and DPL algorithms have been used to solve the problem. The inequalities shown in the second summations of equations (1) and (2) are in effect. A maximum dose of 40 units has been specified for the OAR and not more than 20 units should be received by 20% of the OAR volume. The method of assigning desired doses s i when D-V constraints are specified was described in detail in . The CG method becomes a gradient descent with line search early in the iterative procedure because negative beamlet values appear and continue appearing after a few iterations. Since the results with constraints cannot be compared with the eigenvector solution of the unconstrained case, a correlation coefficient matrix has been calculated corresponding only to the 10 available observations of the 54 variables. It is sufficient to show the first row of that matrix, showing the correlation between the first realization and the remaining nine. Table 1 shows those coefficients.
To the extent that has been investigated for this algorithm, there appears to be no degeneracy, provided that sufficient iterations are carried out.
A different analysis tool has been investigated, this time in relation with DPL optimizations of the constrained problem. The DPL algorithm has been stopped at 200 and 2000 iterations and the differences between the eigenvalue spectra at the two stopping points have been calculated. This has been done by expanding the optimized beamlet weights into their eigenvector components, using the expansion of equations (15) and (16), and subtracting them. Figure 6 shows the difference in the eigenvalue spectra for one specific realization. It is evident that the principal differences are at the high spatial frequencies.
As an interesting exercise, allowed by the small size of the problem, up to 200 000 iterations have been tested with the DPL for each of 10 independent realizations. At that point, the change in likelihood between successive iterations is of the order of 10 −14 and the likelihood values appear to cluster around two points: −3.179 53 and −3.188 43, indicating the existence of multiple extrema. This is a limited result and it is possible that optimizing more independent realizations would yield more terminal points. The application of the D-V constraints to the problem can be expected to lead to multiple extrema found, as discussed in the introduction.
The ASA algorithm has yielded results that are well correlated for the 10 independent realizations, with coefficients between 0.995 and 0.9996, so that one can state that the algorithm, with the algorithm specific parameters described in section 3, yields basically non-degenerate results for this problem, except by early termination. The number of iterations has been approximately 2200 for each realization. One iteration is defined as one complete pass through a randomly ordered set of all beamlet weights, with the random order changing at each iteration.
It should be mentioned that the beamlet weights and their eigenvalue spectra obtained by the CG and the DPL at 2000 iterations, and the ASA at the stopping point, are practically identical, with only some minor differences in the high frequencies. This will not be the case with the second clinical case presented below. Jeraj (2003) has shown how the optimization of a particular clinical case by gradient and simulated annealing methods leads to identical results when only maximum dose constraints for the OAR are specified (no D-V constraints). The problem is known to be convex, Deasy (1997) , and that result should be expected if the algorithms are well implemented. In the case of the present phantom, D-V constraints were specified but only after a very large number of iterations (∼200 000) the small differences between two extrema became evident. The distinction that was discussed in the introduction between degeneracy and multiple extrema is clear in this example. Only terminating the iterative process at a small number of iterations (∼200) degeneracy would appear to exist. By 2000 iterations of the CG degeneracy has practically disappeared, but it is only after a very large number of iterations that one can see multiple extrema.
Results with clinical cases
The first clinical case studied here is a cavernous sinus meningioma that has already been described in detail in , in section 4.2.1 and figure 3, also used in Llacer et al (2003) for a study of multiple local minima effects. The brain stem, the left optic nerve and the optic chiasm are OARs, the former two being adjacent to the PTV over a substantial surface. A total of 891 beamlets are used in the optimization in seven non-coplanar beam directions, with the dose matrix F having been calculated by the BrainSCAN (2002) software of BrainLAB. The second case is a prostate problem in which the complete bladder and rectum are considered OARs. The femoral heads were originally additional OARs, but they have not been designated as such in this investigation so as to limit, to a substantial extent, the number of rows in the dose matrix. That number is 42 280 without the femoral heads, corresponding to the number of voxels in the PTV and OARs. Please note that the dose matrix is not sparse, as it contains all scattering terms. Figure 7 shows the plane containing the isocentre. A PTV that surrounds the prostate with a margin of 3 mm and the two OARs are shown. This case has been optimized with 2995 beamlets in 7 coplanar beam directions. The BrainSCAN software was also used to calculate the dose matrix, with nominal beamlet cross sections of 3.5 mm × 3.5 mm.
For brevity, Hessian analysis and the eigenvector and CG solutions to the unconstrained problems of the clinical cases will not be presented in detail. Only a discussion on their condition number and convergence properties will be given, as they can provide a strong indication of what can be expected in the constrained problems.
Meningioma case
The condition number for the eigenvalues of the Hessian for this problem is 2.63 × 10 7 , approximately one order of magnitude worse than in the small phantom case. In spite of that, the unconstrained problem can be solved by eigenvector decomposition and by CG iterations with excellent convergence. The results by the two methods have correlation coefficients between 0.999 35 and 0.999 38 at 5000 iterations of the CG method.
For a clinical optimization of this case, the conditions required are shown in table 2. The conditions are quite stringent and, most likely, would be relaxed in clinical practice, as they result in substantial under-dosing of the PTV. The desired dose to the PTV was 80 Gy. Ten independent realizations have been investigated, each with stopping points at 200, 500, 1000, 2000, 5000 and 10 000 iterations. Two hundred iterations would likely be a stopping point in clinical practice, as approximately determined in for this problem. Table 3 shows the top row of the correlation coefficient matrix at the six stopping points. Figure 8 (a) shows a beam's eye view of beam 1 for the first realization and figure 8(b) shows the corresponding view for the third realization at the 200 iteration stopping point in both cases, with a correlation coefficient of 0.6644 between the two. Strong differences are observable and one could conclude that there is degeneracy in the problem. However, at 10 000 iterations, the two views are visually and numerically almost identical, supporting the non-degeneracy of the optimization. It is clear that the 'memory' of the initial random initialization of the beamlet fluences can only be lost after a very large number of iterations.
Figure 9(a) shows the differences in the eigenvector spectrum between the beamlet weights at 200 iterations and at 500 iterations for one of the realizations. Figures 9(b) -(e) show respectively those differences between 500 and 1000 iterations, 1000 and 2000, 2000 and 5000, and 5000 and 10 000 iterations, plotted on the same scale, for the same realization. The plots show that between 200 and 500 iterations, all the eigenvalues change at approximately the same rate. Above 500 iterations, progressively higher spatial frequencies become more important in the changes to the beamlet weights. characteristics is obtained beyond 500 iterations, as the curve for 2000 iterations is practically indistinguishable from that of 500 iterations. The lower dose regions of the stem and the optic nerve do improve somewhat with the higher number of iterations. This raises the following question: what do the high spatial frequency increases do at the high iteration numbers? In order to answer this question, the delivered doses for a number of planes in the patient have been inspected. Figure 11(a) shows the dose delivered with the optimization stopped at 500 iterations at one of the central planes. Figure 11(b) shows the difference between the optimizations at 500 iterations and at 10 000 iterations. Please note that the grey scale for the difference image is magnified by a factor of 10. Zero level is at mid-grey. Indeed, most of the differences are at a high spatial frequency, except in the brain stem, where corrections that seem to originate in specific beamlets are evident. No significant corrections seem to occur at the interface between the PTV and the stem or the optic nerve, as also evidenced by the DVHs of figure 8(b) .
From this limited observation, it would appear that obtaining the best interface between a PTV and adjacent OARs requires that the algorithm has access to the small curvatures represented by the small eigenvalues of the Hessian, but probably there is no clinical need to continue iterating beyond a certain point into the nearly flat part of the cost function, although degeneracy would still be noticeable in the beamlet maps.
Five independent realizations of DPL optimizations have been carried out with the same five stopping points as the CG in number of iterations, using the same first five seeds for the random number generator used in the initialization of the beamlet fluences. There are no major differences between the results obtained with the DPL and those of the CG reported above. The numbers in the correlation results are different from those of table 3, but they agree approximately to one or two significant figures, indicating that the DPL also has 'memory' of the initialization until a large number of iterations have been carried out. The resulting DVHs indicate that at 500 iterations the DPL has basically achieved most of the gain in DVH quality, just as in the CG case. No significant differences are observable when comparing the doses delivered, although the results are, of course, somewhat different.
Five realizations have also been optimized by the ASA algorithm. In this case, the different stopping points were obtained by setting the termination criterion to values of 0.002, 0.001, 0.0005, 0.0002 and 0.0001. The maximum number of iterations corresponded to the smallest criterion, with approximately 1200 iterations. For the largest criterion, the number of iterations was approximately 260. The 'time constant' for the decrease of the size of the test step was 300 iterations, so that the principal variable that determined the quality of the optimization was the smallest step size at the end of the process.
The correlation coefficients obtained were approximately 0.86, 0.93, 0.97, 0.98 and 0.99 for the five termination criteria, indicating that with sufficient number of iterations, the stochastic algorithm can reach a nearly unique solution for this problem. That solution is almost identical to the solution obtained by the CG algorithm at a large number of iterations. The fact that the ASA is stochastic in nature does not prevent it from reaching the same solution as the CG, with enough iterations, for this medium size problem. This was also the case with the small phantom example used above.
As a conclusion of the analysis of the optimizations for the Meningioma case with the CG, DPL and ASA algorithms, it appears correct to state that there is no degeneracy if sufficient iterations are carried out, there is no apparent benefit in continuing iterations after a certain point, approximately 500 iterations for the CG and DPL and 200 for the ASA, and the needed high frequency response to obtain a separation between the PTV and the OARs is available to the algorithms without an excessive number of iterations. The issue of beam map complexity, that impacts the delivery of optimizations with multi-leaf collimators, will be discussed in the final section of this paper.
Prostate case
The eigenvalues of the Hessian for this problem result in a very unfavourable condition number of 2.23 × 10 11 , four orders of magnitude worse than for the meningioma case. For the unconstrained problem, it is found that the iterative CG algorithm cannot reach the eigenvector decomposition solution even after 5000 iterations, having tested that result with five independent realizations. It would appear then that a clinical constrained solution may remain degenerate even after a very high number of iterations.
Ten independent realizations have been investigated with the CG algorithm stopping at 500, 1000, 2000 and 10 000 iterations, with the constraints shown in table 4. In addition, five realizations have been optimized with the DPL with the same stopping points and five more have been optimized with the ASA algorithm, with stopping thresholds of 0.002, 0.001, 0.0005, 0.0002 and 0.0001. The dose desired for the PTV was 80 Gy. The behaviour that was observed in the meningioma case has become much clearer in this more complex case. The CG algorithm showed significant improvement in the DVHs until iteration 1000. Beyond that number of iterations, improvements were insignificant. Figure 12 shows the changes in DVHs between iterations 500 and 1000.
The DPL algorithm had practically attained the best DVHs at iteration 500. The ASA with a threshold of 0.001 also had attained the best DVHs. Further iterations with the two algorithms resulted in insignificant improvements. Figure 13 shows the very small differences in DVHs at the stopping points described. The eigenvector spectra of the beamlet weights at the selected stopping points are shown in figure 14 . It is evident that the optimization results include the highest spatial frequencies with moderate coefficients. It is only with higher iteration numbers that the high frequency coefficients grow strongly. The most evident difference in the spectra of figure 14 is the increase of low-to-medium spatial frequencies when going from CG to DPL and to ASA results. The observed differences are seen in any of the realizations that have been examined. They may be related to beamlet map complexity, discussed below.
At the selected stopping points, the CG optimizations still show substantial degeneracy, with correlation coefficients of approximately 0.86. The DPL results show the highest 'memory' of the random initial beamlet values, with correlation coefficients of approximately Although the number of independent realizations is limited in this study, there is evidence that a clinical case with a very unfavourable condition number may show substantial degeneracy at any reasonable number of iterations. The solution would have to traverse regions with very small gradients in parameter space in order to reach a single or one of multiple extrema.
Practical considerations
In this section we will consider the practical effects that the above results have on the use of optimization algorithms for the two target functions described in section 2. The points that will be raised are: (1) choice of starting point, (2) choice of stopping point, (3) effects of filtering and (4) requirements for an improved filtering method.
Choice of starting point
If the optimization algorithm exhibits 'memory' of the beamlet initialization at the chosen stopping point, it would appear that starting with a uniform field of beamlet fluences would be the most favourable choice for delivery by MLCs. In order to elaborate on this point, it will be useful to bring in a fluence map complexity (FMC) index from . It was described as
where η ∈ N j is a neighbourhood around a beamlet j and λ η are weights given to each neighbour. The FMC responds to the differences between adjacent beam weights: each term in the summation inside the square root goes to zero if the fluence a j is equal to its two lateral neighbours, which have λ η = 0.5 assigned to them. For a beam in the periphery, λ η of its only lateral neighbour is set to 1.0. Only adjacent beamlets in the same plane and beam angle form a neighbourhood. The square root and the normalization by the sum of all fluences are intended to lead to numbers that are reasonable for comparisons.
As an example, the FMC values for three randomly initialized realizations of the prostate case have been calculated at 1000 iterations of the CG, for 500 iterations of the DPL and at a stopping threshold of 0.001 for the ASA algorithm. Then, the FMC for an optimization done with a uniform initialization for each of the three algorithms has been calculated. The uniform initialization is done by setting all beamlet fluences to 1.0, computing the average dose to the PTV and normalizing the beamlets to bring that average to the desired dose. Table 5 shows the FMC results obtained.
With uniform initialization, the DPL undergoes the most significant improvement in the FMC. This higher degree of 'memory' of the initial beamlet values has a theoretical basis in the theory of the maximum likelihood estimator (MLE), the origin of the DPL method. In Llacer et al (1989) , the parameter values at the beginning of an iteration of the MLE are shown formally to correspond to the best prior information available about the solution at that point in the process. As such, they will affect the inversion process until convergence is achieved, at which point a single (possibly flat) maximum of the likelihood is arrived. That maximum is independent of the prior information. Thus, if we want to achieve the smoothest beamlet maps at a stopping point still relatively far from convergence, a uniform initialization is called for.
The behaviour of the FMC of the ASA algorithm is worth noting at the chosen practical number of iterations. Starting with a uniform initialization does not lower the FMC with respect to the randomly initialized optimizations. This effect has been observed repeatedly. One can say that the ASA, or other stochastic algorithms, have no 'memory' of where they started from because they do not follow a well-defined path down the gradient lines. Those lines start at the initialization point and end somewhere in the low gradient part of parameter space. Instead, stochastic methods keep jumping from one gradient line to another.
The differences between FMC values of 0.0136 and 0.0196 for the DPL and ASA methods are substantial. Figure 15 , left and right, shows the beam's eye view of the beamlet fluences for the beam at a gantry angle of 210
• for the prostate case, for uniform initialization of the DPL and ASA methods, respectively. Each row appears left justified in the images. Both images are shown with the same grey scale.
We conclude that, certainly for the CG and DPL methods, the best starting point is a uniform beamlet initialization. This probably generalizes to gradient methods other than the CG. On the other hand, for the ASA (and probably other stochastic methods), the degree of complexity of the optimized beamlet maps will be independent of starting point, although the actual map values will depend on that point, unless an extremely large number of iterations is used.
Choice of stopping point
Implementations of gradient methods by other researchers or in commercial software packages can be expected to differ substantially from the CG methodology used in the work reported here. Nevertheless, it may be useful to mention that the stopping points at the number of iterations described above as desirable correspond, approximately, to relative changes in the square root of the cost function of 1 × 10 −5 per iteration, after normalization by the initial square root of the cost. For the DPL, it has been found practical to measure the change in log likelihood between iterations, which is faster and more accurate than measuring the actual log likelihood. For the two clinical problems examined here, the desirable stopping points correspond to a change of log likelihood of approximately 1 × 10 −5 . The stopping conditions for the ASA method have already been described.
Effects of filtering
Filtering of the optimized beamlet maps is usually carried out in clinical practice for at least one of two basic reasons: (1) the need to avoid 'hot' beamlets in the periphery of the PTV that occur when those beamlets graze the PTV and the inversion process attempts to compensate for that 'partial volume' effect and (2) the need to smooth the beamlet profiles for easier delivery by multiple leaf collimators within constraints of accelerator time and undesirable collimator transmission dose to the patient. A nonlinear smoothing filter was devised for the DPL algorithm that is based on Bayesian parameter estimation. It penalizes estimates that deviate from some previous knowledge which, in the case of IMRT optimization, is that the beamlet weights are expected to be relatively smooth. The Bayesian filter penalizes solutions that result in large differences between one beamlet fluence and that of its neighbours. The filter acts as a perturbation to the iterative process and is, therefore, inside the optimization loop. As discussed in , it has been possible to incorporate the same filter inside the optimization loops of the CG and ASA methods, although the theoretical support for that incorporation is lacking. The quadratic cost function of equation (1) or the log likelihood of equation (2) are modified by the addition of a third term
with a plus sign for the quadratic function or a minus sign for the log likelihood. The parameter α controls the strength of the filtering operation and the superscript (k) refers to the kth iteration. The other variables have been described in relation to the FMC of equation (20) . In fact, the FMC formula is derived from the Bayesian filtering term. The DPL iterative formula is then modified by the subtraction of the partial derivative of the expression of equation (21) with respect to a j from the two summations in equation (3). Parameter α is normalized automatically for each specific problem so that the filtering operation is a relatively small perturbation to the parameter estimation process.
The filter is equally effective with any of the three algorithms used here. Its effects will only be described for the DPL applied to the prostate case. Several optimizations with different filter parameters have been carried out, this time using changes in likelihood as stopping criteria. A filter parameter has been chosen so that at a stopping threshold of 1 × 10 −5 the FMC value indicates a beam complexity that is favourable for delivery by MLCs. The FMC for the unfiltered case was 0.0137 while that of the filtered results is 0.0031. Figure 16 shows the beam's eye view maps for the 210
• gantry angle of the unfiltered and filtered optimizations. The effectiveness of the filter in removing 'hot' beamlets in the periphery of the PTV is clear and the smoothing of the fluences is evident. Figure 17 shows the DVHs corresponding to the two same optimizations of figure 16. There are substantial differences in both the PTV and OAR curves, with the filtered results being somewhat worse. An attractive alternative filtering method would be to use a Gaussian filter after an unfiltered optimization. As discussed extensively in Romeny (2003) , a Gaussian filter is the only linear filter that does not create any structure or information that was not there initially, it only destroys information and is a low pass filter of the beamlet values. In the absence of a previous 'model' of what the filtered results should look like, the Gaussian filter is the only one proved mathematically to be optimum.
The unfiltered prostate results have been filtered with Gaussians of different widths. In order to obtain a PTV under-dosing that may be acceptable, small kernels have had to be used. In the filtering operations, row-by-row of the beamlet maps, the edges have been padded with the appropriate number of zeros. Also, a renormalization to the total delivered fluence has been carried out after filtering, as the Gaussian kernels were represented by few bins and the kernels were no longer properly normalized. The results for a standard deviation of the Gaussian kernel of 0.75 bins yield a FMC of 0.0039, close to that of the Bayesian filter discussed above. A comparison of the DVHs for the unfiltered and Gaussian filtered beam maps is shown in figure 18. The PTV is somewhat more under-dosed than in the Bayesian filter, but the OARs are somewhat better, a typical tradeoff. What is important to note, though, is that the beamlet maps resulting from the Gaussian filtering show that 'hot' beamlets have not been controlled as well as with the Bayesian filter. Figure 19 shows the beamlet map for the same beam as in figure 16 . Using larger kernels will result in better control, but with further deterioration of the PTV under-dosing. A post-optimization median filter has also been tested with varying sizes of beamlet sequences. Even with a 3-beamlet sequence (with zero padding at edges), the quality of the PTV DVHs suffers strongly and that type of filter has not been considered further, although it controls the hot beamlets very successfully.
Observation of the difference between the eigenvector decompositions of the unfiltered and filtered beamlet fluences shows that all the spatial frequencies in configuration space (the patient dose domain) are affected by the filtering operation, with particular emphasis on the mid-to-low eigenvectors. It is clear that filtering will decrease the high frequencies in the beamlet maps, but the effects on their projection onto the dose domain are not limited to the high frequencies. Otherwise, the eigenvalue analysis does not offer any clear explanation for the deterioration of the DVHs with filtering. For that, we will need to analyse carefully what filters actually do in configuration space.
Space-variant filtering
The analysis of the effects of filtering by a careful observation of the interaction between beamlets and the different patient regions in configuration space is exceedingly hard to carry out in a large example such as the prostate case used above. For that reason, a very simple two-dimensional 'prostate' phantom has been created using the same tools and setup as in the first example in this paper. Its simplicity allows the successful examination of those interactions and the manual modification of the Bayesian filter to correct a substantial part of the damage to the quality of the optimized DVHs with filtering. Figure 20 shows the phantom. It consists of a central ellipse, the PTV, and two other ellipses, a 'bladder' and a 'rectum'. The figure shows the doses delivered to the water phantom by seven equi-angular beams after Bayesian filtering with a particular parameter α, the filter strength of equation (21) . There are 67 beamlets in the optimization. Figure 21 shows a comparison of the DVHs between the unfiltered and filtered results.
A manual beamlet selection procedure has been followed for the purpose of obtaining beamlet candidates for lowered filter factor α in the optimization process. Each one of the beamlets that is used in the optimization has been projected into configuration space and a list has been made of those that fulfil the two following conditions: (1) they are nearly tangential to both the PTV and to one of the OARs, and (2) they leave substantial energy in both the PTV and one of the OARs. The beamlets in the list have the characteristics that, before filtering, they would be attenuated by the optimization process but would loose part of that attenuation in filtering.
The beamlets to the left and/or right of those in the list (when they exist) have also been made part of the list. The latter would be attenuated in filtering while they probably had higher flux before filtering. Three of the selected beamlets that are examples of the chosen ones are shown in figure 22 . The total number of selected beamlets was 15. After the selection, an optimization was carried out in which the filter factor α for those particular beamlets was decreased by a factor of 0.2, in effect creating a space-variant filter particularly tailored to this problem. The DVHs resulting from this optimization, compared to the unfiltered case are shown in figure 23 . The improvement over the space-invariant filter is noticeable and the cost of that improvement in terms of deliverability of the optimized beamlets is relatively small: FMC for unfiltered results was 0.1079, for space-invariant filter was 0.026 and for the space-variant was 0.035.
Summary of results and final discussion
The results of the above rather lengthy exposition can be summarized as follows:
1. Although it applies strictly only to the unconstrained case, the analysis of Alber on the importance of small eigenvalues in the Hessian of a problem is still approximately applicable to the clinical constrained cases studied. As discussed at the end of section 5, the dose matrix F is the same for the unconstrained and the constrained cases and the existence of a flat region in parameter space would affect the optimization of both cases. The clinical meningioma and prostate cases optimized above are good experimental examples of the validity of the Hessian analysis. The eigenvector decompositions of figures 9 and 14 show that eigenvectors with small eigenvalues are well represented at clinically practical stopping points. Adjustment of their contribution during the iterative process requires that those eigenvectors be accessible to the algorithm and that is occurring in the constrained case, as would occur in the unconstrained case. One likely exception to that statement would be if the maximum dose and/or the D-V constraints required for the optimization were so strict that the path followed by the iterative algorithm would stop early in the process before reaching those flat regions. The eigenvector decomposition of such a solution should show near zero contribution from the eigenvectors with small eigenvalues. 2. If enough iterations were to be done with sufficient precision, it can be expected that clinical cases would not suffer from any significant degeneracy, with the algorithms eventually being able to reach some extremum of the corresponding target function, although that may be very difficult to achieve in problems with large dose matrices. 3. From a clinical point of view, there is no evident need to reach a very high number of iterations. The change in the DVHs after a certain stopping point is insignificant.
Further iterations result in an increase in the small eigenvalue components and higher spatial frequencies being generated in the dose distributions, without affecting the quality of the optimization significantly. Only the uniformity of the dose in the PTV improves somewhat at the very high number of iterations. At practical stopping points, degeneracy can still be evident, with a certain degree of 'memory' of the random starting points. 4. For analytical optimizations, a set of uniform beamlet weights, normalized so that the average PTV dose is the desired one, is the initialization that can be expected to yield the smoothest beamlet maps. For stochastic methods, it does not matter whether one starts from a uniform set of beamlet weights or from randomly selected ones. 5. Stopping an iterative procedure at a relatively large number of iterations results in lower under-dosing of the PTV in regions adjacent to OARs. A suitable stopping rule can be found to do that reliably. 6. A Bayesian nonlinear filter used inside the optimization loop controls 'hot' beamlets better than the best linear filter used a posteriori, if one goal is to avoid excessive deterioration of PTV under-dosing. Smoothing of other sections of the beamlet maps can be done relatively well with both types of filter. Median filtering, although it controls 'hot' beamlets very well, results in strong deterioration of the optimization. 7. Some of the unfavourable damage to the PTV in the form of under-dosing that results from filtering can be avoided by using a space-variant filter that 'knows' which beamlets should be filtered with smaller strength parameters.
It is felt that knowledge gained from the work presented here could help obtain better optimizations in clinical practice. It has been shown that eigenvector/value analysis is helpful in understanding why there is visible degeneracy in practical optimization results, but even in a problem with 2995 beamlets (and therefore 2995 eigenvector/values) and a very unfavourable condition number, iterative optimization methods can reach results in a useful clinical time frame that, although still degenerate, are perfectly useful. Eigenvalue analysis has not been helpful in understanding the effects of filtering on the quality of the optimizations, as all eigenvectors play a role in filtering, not only those that result in high spatial frequency modifications on the delivered dose. The improvements that have been discussed at starting and stopping point, and in filtering, may or may not have an impact on the final deliverable sets of leaf sequences in the clinic.
